Aptiv PLC
XMUN:D7A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptiv PLC
XMUN:D7A
|
IE |
|
AngioDynamics Inc
NASDAQ:ANGO
|
US |
|
Aegon NV
AEX:AGN
|
NL |
|
Sinclair Broadcast Group Inc
NASDAQ:SBGI
|
US |
|
T
|
Trinity Biotech PLC
F:TRBA
|
IE |
Wall St Price Targets
D7A Price Targets Summary
Aptiv PLC
According to Wall Street analysts, the average 1-year price target for
D7A is 91.53 EUR with a low forecast of 75.46 EUR and a high forecast of 113.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is D7A's stock price target?
Price Target
91.53
EUR
According to Wall Street analysts, the average 1-year price target for
D7A is 91.53 EUR with a low forecast of 75.46 EUR and a high forecast of 113.45 EUR.
What is the Revenue forecast for Aptiv PLC?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 5 years is -4%.
What is the Gross Profit forecast for Aptiv PLC?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is -4%.
What is the Operating Income forecast for Aptiv PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 5 years is 6%.
What is the Pre-Tax Income forecast for Aptiv PLC?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 24%.
What is the Net Income forecast for Aptiv PLC?
Projected CAGR
67%
Over the last 13 years, the compound annual growth rate for Net Income has been -13%. The projected CAGR for the next 5 years is 67%.